BIOMAT Database Logo BIOMAT Database Logo

Phyllanthus amarus down-regulates hepatitis B virus mRNA transcription and replication. 1996

C D Lee, and M Ott, and S P Thyagarajan, and D A Shafritz, and R D Burk, and S Gupta
Marion Bessin Liver Research Center, Madras, India.

The Phyllanthus amarus plant shows potential for treating hepatitis B virus. To define the mechanism of action of P. amarus, we used HepG2 2.2.15 cells, which support hepatitis B virus replication. P. amarus inhibited hepatitis B virus polymerase activity, decreased episomal hepatitis B virus DNA content and suppressed virus release into culture medium. To examine transcriptional control mechanisms, we used G26 hepatitis B virus transgenic mice, which produce serum HBsAg but neither HBcAg nor virion particles. When P. amarus was administered to transgenic mice, hepatic HBsAg mRNA levels decreased, indicating transcriptional or post-transcriptional down-regulation of the transgene. Increase in hepatitis B virus mRNA expression after stimulation of the glucocorticoid responsive element was also suppressed by P. amarus, suggesting involvement of the hepatitis B virus enhancer in this response. Disruption by P. amarus of hepatitis B virus polymerase activity, mRNA transcription and replication supports its role as an antiviral agent.

UI MeSH Term Description Entries
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D010946 Plants, Medicinal Plants whose roots, leaves, seeds, bark, or other constituent parts possess therapeutic, tonic, purgative, curative or other pharmacologic attributes, when administered to man or animals. Herbs, Medicinal,Medicinal Herbs,Healing Plants,Medicinal Plants,Pharmaceutical Plants,Healing Plant,Herb, Medicinal,Medicinal Herb,Medicinal Plant,Pharmaceutical Plant,Plant, Healing,Plant, Medicinal,Plant, Pharmaceutical,Plants, Healing,Plants, Pharmaceutical
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004261 DNA Replication The process by which a DNA molecule is duplicated. Autonomous Replication,Replication, Autonomous,Autonomous Replications,DNA Replications,Replication, DNA,Replications, Autonomous,Replications, DNA
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription

Related Publications

C D Lee, and M Ott, and S P Thyagarajan, and D A Shafritz, and R D Burk, and S Gupta
Effect of Phyllanthus amarus on duck hepatitis B virus replication in vivo.
December 1990, Journal of medical virology,
C D Lee, and M Ott, and S P Thyagarajan, and D A Shafritz, and R D Burk, and S Gupta
Phyllanthus amarus and hepatitis B.
October 1990, Lancet (London, England),
C D Lee, and M Ott, and S P Thyagarajan, and D A Shafritz, and R D Burk, and S Gupta
In vitro effect of Phyllanthus amarus on hepatitis B virus.
March 1991, The Indian journal of medical research,
C D Lee, and M Ott, and S P Thyagarajan, and D A Shafritz, and R D Burk, and S Gupta
Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus.
October 1988, Lancet (London, England),
C D Lee, and M Ott, and S P Thyagarajan, and D A Shafritz, and R D Burk, and S Gupta
Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus.
October 1988, Lancet (London, England),
C D Lee, and M Ott, and S P Thyagarajan, and D A Shafritz, and R D Burk, and S Gupta
Phyllanthus amarus suppresses hepatitis B virus by interrupting interactions between HBV enhancer I and cellular transcription factors.
November 1997, European journal of clinical investigation,
C D Lee, and M Ott, and S P Thyagarajan, and D A Shafritz, and R D Burk, and S Gupta
Hepatitis B virus and hepatocellular carcinoma--treatment of HBV carriers with Phyllanthus amarus.
January 1989, Cancer detection and prevention,
C D Lee, and M Ott, and S P Thyagarajan, and D A Shafritz, and R D Burk, and S Gupta
Efficacy of Phyllanthus amarus for eradication of hepatitis B virus in chronic carriers.
September 1991, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
C D Lee, and M Ott, and S P Thyagarajan, and D A Shafritz, and R D Burk, and S Gupta
Hepatitis B virus and primary hepatocellular carcinoma: treatment of HBV carriers with Phyllanthus amarus.
March 1990, Vaccine,
C D Lee, and M Ott, and S P Thyagarajan, and D A Shafritz, and R D Burk, and S Gupta
Inhibition of hepatitis C virus replication by herbal extract: Phyllanthus amarus as potent natural source.
June 2011, Virus research,
Copied contents to your clipboard!